Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
manganese sulfate + zinc sulfate + cupric sulfate + selenious acid
- Development stage
- Unknown
- Lead developer
- American Regent
- Modality
- Small Molecules
- Administration
- Intravenous, Parenteral
01
Overview
manganese sulfate + zinc sulfate + cupric sulfate + selenious acid is an injectable fixed-dose combination trace element product for use as an additive to parenteral nutrition solutions. Marketed by American Regent under the brands Tralement for adults and pediatric patients weighing at least 10 kg and Multrys for neonatal and pediatric patients weighing less than 10 kg, it supplies four essential micronutrients: zinc, copper, manganese, and selenium. Its pharmacologic effect is nutritional replacement rather than receptor-mediated drug action; these trace elements function as essential cofactors for enzymes involved in antioxidant defense, immune function, wound healing, connective tissue formation, iron metabolism, growth, and cellular metabolism. It is indicated when oral or enteral nutrition is not possible, insufficient, or contraindicated, and it is not administered by direct intravenous infusion but only as an admixture in a parenteral nutrition solution.
- Brand names
- TralementMultrys
- Other names
- trace elements injection 4trace elements injection 4 pediatric
Beyond the preview
Go deeper on manganese sulfate + zinc sulfate + cupric sulfate + selenious acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on manganese sulfate + zinc sulfate + cupric sulfate + selenious acid.